Clinic
Guadalupe County
Guadalupe County was paid $1.65M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 19% of everything it billed.
33Billing provider infoGUADALUPE COUNTY
SANTA ROSA, NM 88435
SANTA ROSA, NM 88435
33aNPI1346249968assigned 07/15/2005
33bProvider typeClinic/Center
28Total paid$1.65M
24GClaims32,899
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in New Mexico
Rank by total paid#19 of 52
Median peer was paid$827K
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,529 | $366K | |
| 2019 | 5,374 | $347K | |
| 2020 | 3,380 | $163K | |
| 2021 | 2,299 | $138K | |
| 2022 | 4,124 | $194K | |
| 2023 | 5,428 | $194K | |
| 2024incomplete | 5,765 | $247K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 19% | 4,495 | 3,813 | $320K |
| 64493 | 17% | 1,048 | 736 | $281K | |
| 64635 | 13% | 613 | 461 | $217K | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 1,787 | 1,587 | $208K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 5.6% | 234 | 232 | $92K |
| 99152 | 2.9% | 1,251 | 887 | $48K | |
| 80053 | Comprehensive metabolic panel | 2.8% | 4,294 | 3,554 | $47K |
| 87631 | 2.7% | 361 | 350 | $45K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.6% | 184 | 167 | $43K |
| 64450 | 2.5% | 231 | 69 | $41K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.7% | 823 | 742 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 4,083 | 3,303 | $27K |
42 more codes
| 64640 | 1.5% | 110 | $25K | |
| A4649 | Surgical supply; miscellaneous | 1.4% | 249 | $23K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.4% | 496 | $22K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 414 | $21K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 436 | $21K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 517 | $20K |
| 64494 | <1% | 118 | $16K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 389 | $16K |
| 64495 | <1% | 87 | $14K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,905 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 542 | $8K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 76 | $8K |
| J3490 | Unclassified drugs | <1% | 1,245 | $6K |
| 80061 | Lipid panel | <1% | 403 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 144 | $4K |
| 84484 | <1% | 260 | $4K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 288 | $4K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 944 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 119 | $2K |
| 81001 | <1% | 393 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 34 | $2K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 12 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 206 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 345 | $2K |
| 83605 | <1% | 121 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 311 | $1K |
| 83690 | <1% | 122 | $929.86 | |
| 84439 | <1% | 80 | $692.77 | |
| 81002 | <1% | 199 | $682.33 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $674.23 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 708 | $583.76 |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 579 | $562.20 |
| 83735 | <1% | 59 | $423.35 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 15 | $375.28 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 123 | $328.13 |
| 83880 | <1% | 16 | $272.95 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 150 | $271.63 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 120 | $204.25 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 25 | $190.38 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 69 | $178.95 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 26 | $149.13 |
| 86140 | <1% | 27 | $148.37 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTENORIO, FRANKIE (ADMINISTRATOR)